ABBOTT 
Scientific Division 
Abbott Laboratories 
North Chicago, Illinois 60064 
September 28, 1976 
Donald S. Fredrickson, M.D. 
Director 
Dept, of Health, Education and Welfare 
Public Health Service 
National Institutes of Health 
Bethesda, Maryland 20014 
Dear Doctor Fredrickson: 
Thank you kindly for inviting us to submit recommendations on the patent 
applications for recombinant DNA procedures by Stanford University and 
the University of California. Since receiving your letter we have been 
studying and analyzing the possible impacts of various patent options on 
the future beneficial development of this technology. We do intend to 
submit constructive recommendations but we will not have them in hand by 
September 30, because the need for sound and thorough study and in depth 
analysis is requiring additional time. 
We believe that a sound patent position by the NIH can be a key factor 
in the orderly and successful fulfillment of the beneficial potential of 
recombinant DNA technology. We trust you will consider our recommenda- 
tions which we hope to get to you in the next week or so. 
Sincerely yours, 
ABBOTT LABORATORIES 
Director 
Division of Experimental Biology 
LRO: nlm 
[ 98 ] 
